_version_ 1784653280447561728
author Duijvelaar, Erik
Schippers, Job R
Smeele, Patrick J
de Raaf, Michiel Alexander
Vanhove, Arthur L E M
Blok, Siebe G
Twisk, Jos W R
Noordegraaf, Anton Vonk
de Man, Frances S
Bogaard, Harm Jan
Aman, Jurjan
author_facet Duijvelaar, Erik
Schippers, Job R
Smeele, Patrick J
de Raaf, Michiel Alexander
Vanhove, Arthur L E M
Blok, Siebe G
Twisk, Jos W R
Noordegraaf, Anton Vonk
de Man, Frances S
Bogaard, Harm Jan
Aman, Jurjan
author_sort Duijvelaar, Erik
collection PubMed
description
format Online
Article
Text
id pubmed-8853671
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88536712022-02-18 Long-term clinical outcomes of COVID-19 patients treated with imatinib Duijvelaar, Erik Schippers, Job R Smeele, Patrick J de Raaf, Michiel Alexander Vanhove, Arthur L E M Blok, Siebe G Twisk, Jos W R Noordegraaf, Anton Vonk de Man, Frances S Bogaard, Harm Jan Aman, Jurjan Lancet Respir Med Correspondence Elsevier Ltd. 2022-04 2022-02-17 /pmc/articles/PMC8853671/ /pubmed/35183270 http://dx.doi.org/10.1016/S2213-2600(22)00052-2 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Duijvelaar, Erik
Schippers, Job R
Smeele, Patrick J
de Raaf, Michiel Alexander
Vanhove, Arthur L E M
Blok, Siebe G
Twisk, Jos W R
Noordegraaf, Anton Vonk
de Man, Frances S
Bogaard, Harm Jan
Aman, Jurjan
Long-term clinical outcomes of COVID-19 patients treated with imatinib
title Long-term clinical outcomes of COVID-19 patients treated with imatinib
title_full Long-term clinical outcomes of COVID-19 patients treated with imatinib
title_fullStr Long-term clinical outcomes of COVID-19 patients treated with imatinib
title_full_unstemmed Long-term clinical outcomes of COVID-19 patients treated with imatinib
title_short Long-term clinical outcomes of COVID-19 patients treated with imatinib
title_sort long-term clinical outcomes of covid-19 patients treated with imatinib
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853671/
https://www.ncbi.nlm.nih.gov/pubmed/35183270
http://dx.doi.org/10.1016/S2213-2600(22)00052-2
work_keys_str_mv AT duijvelaarerik longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT schippersjobr longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT smeelepatrickj longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT deraafmichielalexander longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT vanhovearthurlem longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT bloksiebeg longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT twiskjoswr longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT noordegraafantonvonk longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT demanfrancess longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT bogaardharmjan longtermclinicaloutcomesofcovid19patientstreatedwithimatinib
AT amanjurjan longtermclinicaloutcomesofcovid19patientstreatedwithimatinib